Analysts Peeling Back the Layers on LeMaitre Vascular, Inc. (NASDAQ:LMAT)
LeMaitre Vascular, Inc. (NASDAQ:LMAT) currently has an A verage Broker Rating of 2. This number is based on the 4 sell-side firms polled by Zacks. The ABR rank within the industry stands at 58. Analysts on a consensus basis are expecting that the stock will reach $37.6 within the year. The ABR is provided by Zacks which simplfies analyst ratings into an integer based number. They use a one to five scale where they translate brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 represents a consensus Sell rating.
An evaluation of a stock’s expected performance and/or its risk level as judged by a rating agency such as Standard and Poor’s. A stock rating will usually tell the inves ...